BE831350A - Nouveaux esters cetoniques - Google Patents

Nouveaux esters cetoniques

Info

Publication number
BE831350A
BE831350A BE158285A BE158285A BE831350A BE 831350 A BE831350 A BE 831350A BE 158285 A BE158285 A BE 158285A BE 158285 A BE158285 A BE 158285A BE 831350 A BE831350 A BE 831350A
Authority
BE
Belgium
Prior art keywords
new
ketonic
esters
ketonic esters
new ketonic
Prior art date
Application number
BE158285A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE831350A publication Critical patent/BE831350A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D461/00Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE158285A 1974-06-21 1975-07-14 Nouveaux esters cetoniques BE831350A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7421581A FR2275209A1 (fr) 1974-06-21 1974-06-21 Nouveaux esters cetoniques, leurs sels, leur preparation et les medicaments qui les renferment

Publications (1)

Publication Number Publication Date
BE831350A true BE831350A (fr) 1976-01-14

Family

ID=9140347

Family Applications (1)

Application Number Title Priority Date Filing Date
BE158285A BE831350A (fr) 1974-06-21 1975-07-14 Nouveaux esters cetoniques

Country Status (2)

Country Link
BE (1) BE831350A (fr)
FR (1) FR2275209A1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US6417204B1 (en) 2000-07-07 2002-07-09 Medicure International Inc. Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6605612B2 (en) 2000-02-29 2003-08-12 Medicure International Inc. Cardioprotective phosohonates and malonates
US6677356B1 (en) 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1148733B (it) * 1980-11-14 1986-12-03 Medea Res Srl Derivati della vincamina,metodo per la sua preparazione e composizione farmaceutiche che lo contengono

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890943B2 (en) 1999-03-08 2005-05-10 Medicure Inc. Pyridoxal analogues and methods of treatment
US7230009B2 (en) 1999-03-08 2007-06-12 Medicure, Inc. Pyridoxal analogues and methods of treatment
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
US7148233B2 (en) 1999-08-24 2006-12-12 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US7144892B2 (en) 1999-08-24 2006-12-05 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US7132430B2 (en) 1999-08-24 2006-11-07 Medicure International Inc. Treatment of cardiovascular and related pathologies
US6677356B1 (en) 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7125889B2 (en) 1999-08-24 2006-10-24 Medicure International Inc. Treating of cardiovascular and related pathologies
US7115625B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7115626B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US6605612B2 (en) 2000-02-29 2003-08-12 Medicure International Inc. Cardioprotective phosohonates and malonates
US7105673B2 (en) 2000-02-29 2006-09-12 Medicure International Inc. Cardioprotective phosphonates and malonates
US6867215B2 (en) 2000-02-29 2005-03-15 Medicure International Inc. Cardioprotective phosphonates and malonates
US6780997B2 (en) 2000-02-29 2004-08-24 Medicure International Inc. Cardioprotective phosphonates and malonates
US6667315B2 (en) 2000-02-29 2003-12-23 Medicure International Inc. Cardioprotective phosphonates and malonates
US6861439B2 (en) 2000-03-28 2005-03-01 Medicure International, Inc. Treatment of cerebrovascular disease
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6417204B1 (en) 2000-07-07 2002-07-09 Medicure International Inc. Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Also Published As

Publication number Publication date
FR2275209A1 (fr) 1976-01-16
FR2275209B1 (fr) 1978-08-11

Similar Documents

Publication Publication Date Title
FR2273545A1 (fr) Nouveaux benzimidazols
FR2302093A1 (fr) Nouveaux esters alkyliques
BE825096A (fr) Nouveaux colorants
BE825086A (fr) Esters
FR2300081A1 (fr) Nouveaux d
FR2274300A1 (fr) Antiarrhythmiques nouveaux
BE815590A (fr) Nouveaux esters des 21-thiol-steroides
FR2290189A1 (fr) Nouveaux glycerides anti-inflammatoires
FR2286611A1 (fr) Perruque
BR7503374A (pt) Estrutura amortecida
IT1031961B (it) Esteri polimerizzabili
BE831350A (fr) Nouveaux esters cetoniques
FR2300068A1 (fr) Esters
FR2306983A1 (fr) Nouveaux tetrazole-thiols
BE836844A (fr) Nouveaux anesthetiques locaux
BE814418A (fr) Nouveaux esters cycloalcoyl-alcoyliques
FR2298330A2 (fr) Nouveaux d
BE836254A (fr) Nouveaux insecticides
BE823879A (fr) Nouveaux esters de benzofuranne-5-yle
BE827797A (fr) Nouveaux terpenophenols
BE835637A (fr) Nouveaux n-phenylcarbamates
DK370075A (da) Forbedret standkonstruktion
TR19268A (tr) Yeni esterler
BE813170A (fr) Cephalosporine-sulfonates (esters)
SE7601510L (sv) Tetrabromxylylendiestrar